Showing results (151-160 of 174) with videos related to
Sort By:
Pageof 18
Annals of Hematology|July 4, 2024
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysisJing Zheng, Yanmin Zhao, Yi Luo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic LeukemiaYongxian Hu, Zhao Wu, Yi Luo, et al.Current Research in Translational Medicine|July 5, 2020
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challengesYongxian Hu, Elaine Tan Su Yin, Yingying Yang, et al.Bone Marrow Transplantation|December 13, 2025
Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapyPingnan Xiao, Xin Zhao, Linqin Wang, et al.Nature Communications|September 9, 2022
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignanciesYongxian Hu, Jingjing Li, Fang Ni, et al.Oncoimmunology|April 14, 2017
Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective studyYamin Tan, Haowen Xiao, Depei Wu, et al.Bone Marrow Transplantation|August 7, 2019
Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapyXiujian Wang, Yongxian Hu, Xiao Liu, et al.Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.Nature|August 31, 2022
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHLJiqin Zhang, Yongxian Hu, Jiaxuan Yang, et al.Nature Medicine|September 24, 2025
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialJingjing Feng, Dawei Huo, Ruimin Hong, et al.Pageof 18